
October 20, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Seaberg, Wayne Paterson, admedus

October 20, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MedImmune, Working Life, bing yao

October 17, 2014 Manufacturing and Production, Research and Development, Sales and Marketing Ebola, GSK, JK-05, Sihuan, tekmira, vaccines, zmapp

October 17, 2014 Research and Development, Sales and Marketing BMS, CLL, Cancer, Gazyva, Pharmacyclics, Roche, imbruvica, leukaemia
October 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kate Aldous, Katy Pogson, Matt Lowe, Red Door Communications, Sarah Aldridge

October 16, 2014 Research and Development, Sales and Marketing Cancer, Herceptin (trastuzumab), Kadcyla, Perjeta, Q3, Roche, ado-trastuzumab emtansine, pertuzumab

October 16, 2014 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, CRUK, Cambridge, MRC, MedImmune

October 16, 2014 Research and Development, Sales and Marketing Boehringer, ERS, Esbriet, FDA, IPF, InterMune, Roche, US, lung scarring, lungs, ofev

October 16, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jackie Scanlan, Novo Nordisk

October 15, 2014 Medical Communications, Research and Development, Sales and Marketing BT, cloud, exostar, iam, life sciences, software, workbench

October 15, 2014 Research and Development, Sales and Marketing Eisai, FDA, Helsinn, akynzeo, chemotherapy, cinv

October 15, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ken Sutherland, Scottish Lifesciences Association

October 14, 2014 Research and Development, Sales and Marketing BMS, Janssen, Pharmacyclics, imbruvica, opdivo
October 14, 2014 Research and Development, Sales and Marketing ABPI, NHS, NICE, UK, WHO, Whitehead
October 14, 2014 Research and Development, Sales and Marketing FDA, Femera, LEE011, Pfizer, bemaciclib, breast cancer, palbociclib